World
Results of Q1 2022 Group sales increase by 12.2% to € 5.2 billion; EBITDA pre up 7.8% to € 1.6 billion; EBITDA pre margin 31.3% Growth story ...
May 13, 2022 | News
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...
May 11, 2022 | News
Merck, a leading science and technology company, aims to significantly reduce its greenhouse gas emissions by 2030. The independent Science Based Targ...
May 10, 2022 | News
Genovac, a leading contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for therapeutic, diagno...
May 03, 2022 | News
To combat these challenges, biopharmaceuticals that are produced with the help of living organisms are playing an increasingly important role. However, the...
April 21, 2022 | Opinion
ZooMAb® antibodies becomes the first-ever antibody to be recognized for low-environmental impact by My Green Lab ZooMAb® antibodies ra...
April 19, 2022 | News
Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMB...
April 14, 2022 | News
Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digita...
April 14, 2022 | News
Jackson ImmunoResearch, manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new range of detection reagents th...
April 13, 2022 | News
Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal ...
April 05, 2022 | News
Waters Corporation (NYSE:WAT) today introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its...
March 31, 2022 | News
Transformation focuses on reducing complexity and developing an innovative, digital culture to better understand and address unmet medical needs Boehringe...
March 30, 2022 | News
The National Comprehensive Cancer Network® (NCCN®) today announced new translations of the recently-published NCCN Guidelines for Pa...
March 28, 2022 | News
i) an agreement for Innovent to obtain the sole commercialization rights to import, market, promote, distribute and detail Cyramza® (ramucirumab) ...
March 28, 2022 | News
Most Read
Bio Jobs
News